Palliative Care for High-Grade Glioma

高级别胶质瘤的姑息治疗

基本信息

项目摘要

Brief Summary WHO Grade III and IV gliomas (high-grade glioma or HGG) are aggressive, malignant primary brain tumors that are devastating for older adult patients and caregivers due to high symptom burden, early physical and cognitive decline, caregiver support needs, and existential distress stemming from life expectancy on the order of months. Palliative care, defined by the National Quality Forum as “patient and family-centered care that optimizes quality of life by anticipating, preventing, and alleviating suffering across the continuum of a patient's illness”, is well-suited to meet the complex needs of these patients. Multiple oncological societies recommend that palliative care be integrated early (within 3 months of diagnosis) into the treatment plan of all cancer patients. Older adults have particularly high palliative care needs, in part due to shorter prognosis and decreased tolerance for standard cancer-directed therapy. Generally, palliative care needs may be addressed through a combination of primary palliative care (delivered by any front-line provider, including neuro- oncologists) and/or specialty palliative care (delivered by a provider or multidisciplinary team with advanced palliative care training and certification). The current literature suggests that patients with HGG do not have all their palliative care needs met through primary palliative care from neuro-oncologists, yet they also are not referred to specialty palliative care until they are actively dying. There is no established model for ensuring their palliative care needs are met throughout the disease course. In this proposal, I present a conceptual model of the barriers to comprehensive, timely palliative care for patients with HGG. My career goal is to improve the delivery of palliative care for older adults with HGG. In this proposal I will: 1) use qualitative methods to assess the range of knowledge, experience, and strength of preferences of older adults with HGG, their caregivers, neuro-oncologists, and palliative medicine specialists regarding the domains of palliative care and the optimal balance of primary and specialty palliative care for each domain; 2) use an existing cohort of patients with HGG from a large health delivery system to measure the extent to which services or care processes in each palliative care domain are delivered, and to analyze the associations between palliative care delivery and overall HGG health care utilization. These two projects will be combined with my career development plan, for which I have identified a team of expert mentors and advisors and am proposing coursework relating to qualitative research methods and implementation science, as well as clinical rotations and didactic learning about core concepts in geriatrics and aging research. This will set me on a path to obtain a future career development award, which is the first step on my path to becoming an independent investigator whose work improves the care of older adults with HGG.
简要摘要 WHO III级和IV胶质瘤(高级神经胶质瘤或HGG)是侵略性的,恶性的原发性脑肿瘤 由于伯恩伯恩(Burnen)高症状,早期身体和 认知能力下降,护理人员的支持需求以及现有的遇到命令预期寿命的困扰 几个月。姑息治疗,由国家质量论坛定义为“耐心和以家庭为中心的护理 通过预测,预防,预防和减轻患者连续性的痛苦来优化生活质量 疾病”非常适合满足这些患者的复杂需求。推荐多个肿瘤社会 姑息治疗及早(在诊断后的3个月内)纳入所有癌症的治疗计划 患者。老年人的姑息治疗需求特别高,部分原因是预后较短和 标准癌症指导治疗的公差降低。通常,可以解决姑息治疗需求 通过主要的姑息治疗(由任何一线提供商提供,包括神经 - 肿瘤学家)和/或专业姑息治疗(由提供者或多学科团队提供高级 姑息治疗培训和认证)。目前的文献表明,HGG患者没有全部 他们的姑息治疗需求是通过神经肿瘤学家的初级姑息治疗满足的,但他们也不是 提到专业姑息治疗,直到积极死亡。没有确保的既定模型 在整个疾病过程中,他们的姑息治疗需求得到满足。在此提案中,我提出了一个概念 HGG患者的全面,及时姑息治疗的障碍模型。我的职业目标是 改善HGG的老年人的姑息治疗。在此提案中,我将:1)使用定性 评估HGG老年人偏好的知识,经验和强度范围的方法, 他们的护理人员,神经肿瘤学家和姑息医学专家有关姑息治疗领域 以及每个领域的初级和专业姑息治疗的最佳平衡; 2)使用现有的队列 来自大型健康分娩系统的HGG患者,以衡量服务或护理的程度 每个姑息治疗领域的过程都可以交付,并分析姑息治疗之间的关联 交付和总体HGG医疗保健利用。这两个项目将与我的职业相结合 发展计划,我已经确定了一组专家导师和顾问团队,并正在提议 与定性研究方法和实施科学以及临床轮换有关的课程工作 以及关于老年医学和衰老研究中核心概念的教学学习。这将使我走上一条途径 未来的职业发展奖,这是我成为独立调查员之路的第一步 他们的工作改善了HGG的老年人的照顾。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rita Caroline Crooms其他文献

Rita Caroline Crooms的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rita Caroline Crooms', 18)}}的其他基金

Palliative Care for High-Grade Glioma
高级别胶质瘤的姑息治疗
  • 批准号:
    10302641
  • 财政年份:
    2021
  • 资助金额:
    $ 16.9万
  • 项目类别:

相似国自然基金

成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
  • 批准号:
    82302025
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
  • 批准号:
    82302311
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Implementing Advance Care Planning as a Healthy Aging Activity in Rural Primary Care
在农村初级保健中实施预先护理计划作为健康老龄化活动
  • 批准号:
    10557515
  • 财政年份:
    2023
  • 资助金额:
    $ 16.9万
  • 项目类别:
The Promoting Resilience in Stress Management (PRISM) Intervention: a multi-site randomized controlled trial for Adolescents and Young Adults with advanced cancer
促进压力管理复原力 (PRISM) 干预:一项针对患有晚期癌症的青少年和年轻人的多中心随机对照试验
  • 批准号:
    10895146
  • 财政年份:
    2023
  • 资助金额:
    $ 16.9万
  • 项目类别:
Improving Serious Illness Care for Underserved Populations: Patient and Caregiver Experience with Tele-Palliative Care
改善服务不足人群的重病护理:患者和护理人员的远程姑息护理体验
  • 批准号:
    10635741
  • 财政年份:
    2023
  • 资助金额:
    $ 16.9万
  • 项目类别:
Mentoring Researchers in Advance Care Planning for Underrepresented Older Adults at Risk for Alzheimer’s Disease and Related Dementias and Their Caregivers
指导研究人员为面临阿尔茨海默病和相关痴呆症风险的代表性不足的老年人及其护理人员进行预先护理计划
  • 批准号:
    10587383
  • 财政年份:
    2023
  • 资助金额:
    $ 16.9万
  • 项目类别:
Facilitating Advance Care Planning Discussions Between Patients with Advanced Cancer and Their Family Caregivers Using a Resilience-Building Intervention
使用增强复原力的干预措施促进晚期癌症患者及其家庭护理人员之间的预先护理计划讨论
  • 批准号:
    10661890
  • 财政年份:
    2023
  • 资助金额:
    $ 16.9万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了